You can purchase shares of INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (OTCQB:INTI) through any online brokerage.
There are no as such competitors for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc..
There is no analysis for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. to provide a consensus price target.
The stock price for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. (OTCQB: INTI) is $0.079 last updated November 3, 2026 at 2:25 PM EST.
There are no upcoming dividends for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc..
INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc..
INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
Inhibitor Therapeutics Inc is a pharmaceutical development company focused on developing and potentially commercializing therapeutics based on already approved active pharmaceutical ingredients, with a primary focus on basal cell carcinoma nevus...